PPIDT00084
Drug Information
| Name | Interferon alfa-2b |
|---|---|
| Sequence | CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMNEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE |
| DrugBank_ID | DB00105 |
| Type | biotech |
| Indication | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, lyophilized, for solution | — |
0.3 mg
|
| Injection, powder, for solution | — |
10 MIU/1vial
|
| Injection, powder, for solution | — |
3 miu/1vial
|
| Injection, powder, for solution | — |
5 miu/1vial
|
| Injection, powder, for solution; kit | Intralesional; Intramuscular; Intravenous; Subcutaneous |
38 ug/1mL
|
| Injection, powder, for solution; kit | Intramuscular; Intravenous; Subcutaneous |
192 ug/1mL
|
| Injection, powder, for solution; kit | Intramuscular; Intravenous; Subcutaneous |
69 ug/1mL
|
| Injection, solution | Intralesional; Intramuscular; Subcutaneous |
19.2 ug/0.5mL
|
| Injection, solution | Intramuscular; Subcutaneous |
11.6 ug/0.5mL
|
| Injection, solution | Subcutaneous |
11.6 ug/0.2mL
|
| Injection, solution | Subcutaneous |
19.2 ug/0.2mL
|
| Injection, solution | Subcutaneous |
38.4 ug/0.2mL
|
| Kit | Intralesional; Intramuscular; Intravenous; Subcutaneous |
38 ug/1mL
|
| Kit | Intramuscular; Intravenous; Subcutaneous |
192 ug/1mL
|
| Kit | Intramuscular; Intravenous; Subcutaneous |
69 ug/1mL
|
| Kit; liquid; powder, for solution | Intralesional; Intramuscular; Intravenous; Subcutaneous |
|
| Liquid | Subcutaneous |
15000000 unit / mL
|
| Liquid | Subcutaneous |
25000000 unit / mL
|
| Liquid | Subcutaneous |
50000000 unit / mL
|
| Liquid; powder, for solution | Intralesional; Intramuscular; Intravenous; Subcutaneous |
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
10000000 unit / mL
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
6000000 unit / mL
|
| Liquid; powder, for solution | Intralesional; Intramuscular; Subcutaneous |
|
| Liquid | Intralesional; Intramuscular; Subcutaneous |
5000000 unit / mL
|
| Liquid | Subcutaneous |
10000000 unit / vial
|
| Liquid | Subcutaneous |
3000000 unit / vial
|
| Liquid | Subcutaneous |
5000000 unit / vial
|
| Injection | Subcutaneous |
18 miu
|
| Injection | Subcutaneous |
30 miu
|
| Injection | Parenteral |
300000000000 IU
|
| Injection | Parenteral |
500000000000 IU
|
| Injection, solution | — |
10 miu/1ml
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
18 miu
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
30 miu
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
60 miu
|
| Injection | Subcutaneous |
18000000 IU
|
| Injection | Subcutaneous |
30000000 IU
|
| Injection | Subcutaneous |
60000000 IU
|
| Injection, powder, for solution | Intravenous; Parenteral; Subcutaneous |
3000.000 IU
|
| Injection, powder, for solution | Intravenous; Parenteral; Subcutaneous |
30000.000 IU
|
| Injection, powder, for solution | Intravenous; Subcutaneous |
1000.000 IU/0.5ml
|
| Injection, powder, for solution | Intravenous; Subcutaneous |
10000.000 IU/0.5ml
|
| Injection, powder, for solution | Intravenous; Subcutaneous |
18000.000 IU
|
| Injection, powder, for solution | Intravenous; Subcutaneous |
5000.000 IU
|
| Injection, solution | Intravenous; Parenteral; Subcutaneous |
25000.000 IU
|
| Injection, solution | Intravenous; Parenteral; Subcutaneous |
25000.000 IU/2.5ml
|
| Injection, solution | Intravenous; Parenteral; Subcutaneous |
3000.000 IU
|
| Injection, solution | Intravenous; Subcutaneous |
10000.000 IU/0.5ml
|
| Injection, solution | Intravenous; Subcutaneous |
10000000 IU/ml
|
| Injection, solution | Intravenous; Subcutaneous |
18000.000 IU/3ml
|
| Injection, solution | Intravenous; Subcutaneous |
18000.000 IU
|
| Injection, solution | Intravenous; Subcutaneous |
18000000 IU/3ml
|
| Injection, solution | Intravenous; Subcutaneous |
25000000 IU/2.5ml
|
| Injection, solution | Intravenous; Subcutaneous |
3000000 IU/0.5ml
|
| Injection, solution | Intravenous; Subcutaneous |
5000.000 IU
|
| Injection, solution | Intravenous; Subcutaneous |
5000000 IU/0.5ml
|
| Injection, solution | Parenteral; Subcutaneous |
18000.000 IU
|
| Injection, solution | Parenteral; Subcutaneous |
30000.000 IU
|
| Injection, solution | Parenteral; Subcutaneous |
60000.000 IU
|
| Injection, solution | Subcutaneous |
18000.000 IU
|
| Capsule; kit; liquid | Oral; Subcutaneous |
|
| Injection, powder, for solution | Subcutaneous |
|
| Injection, powder, for solution | Subcutaneous |
10 MIU
|
| Injection, solution | Subcutaneous |
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P48551 | IFNAR2 | Interferon alpha/beta receptor 2 | Homo sapiens | binder | Link |
| target | P01563 | IFNA2 | Interferon alpha-2 | Homo sapiens | modulator | Link |
| target | P17181 | IFNAR1 | Interferon alpha/beta receptor 1 | Homo sapiens | binder | Link |
| enzyme | P05177 | CYP1A2 | Cytochrome P450 1A2 | Homo sapiens | inhibitor | Link |